A new single gene deletion on 2q34: ERBB4 is associated with intellectual disability

American Journal of Medical Genetics, Part A

Volumn 161, Issue 6, 2013, Pages 1487-1490

  Kasnauskiene, Jurate ^a   Ciuladaite, Zivile ^a   Preiksaitiene, Egle ^a   Utkus, Algirdas ^a   Peciulyte, Agne ^a   Kučinskas, Vaidutis ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

2q34 deletion; ERBB4 gene; Intellectual disability

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; ERBB4 PROTEIN, HUMAN;

2Q34 DELETION; ADOLESCENT; ARTICLE; CASE REPORT; CENTROMERE; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL EVALUATION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; ERBB4 GENE; EXON; FACE DYSMORPHIA; GENE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CODE; HAPLOINSUFFICIENCY; HAPLOTYPE; HUMAN; HYPERACTIVITY; INTELLECTUAL IMPAIRMENT; INTRON; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; SPEECH DELAY; TYPE I TRANSMEMBRANE TYROSINE KINASE RECEPTOR GENE; CHROMOSOME 2; CHROMOSOME BANDING PATTERN; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; INTELLECTUAL DISABILITY; KARYOTYPE;

ADOLESCENT; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 2; COMPARATIVE GENOMIC HYBRIDIZATION; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HAPLOINSUFFICIENCY; HUMANS; INTELLECTUAL DISABILITY; KARYOTYPE; MALE; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-4;

EID: 84878263084     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35911     Document Type: Article

References (14)

1. Backx L, Ceulemans B, Vermeesch JR, Devriendt K, Van Esch H. 2009. Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4. Eur J Hum Genet 17:378-382.
2. Banerjee A, Macdonald ML, Borgmann-Winter KE, Hahn CG. 2010. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Brain Res Bull 83:132-139.
3. Gassman M, Casagranda F, Orioll D, Simon H, Lai C, Klein R, Lemke G. 1995. Aberrant neural and cardiac development in mice lacking the erbB4 neuregulin receptor. Nature 378:390-394.
4. Gerlai R, Pisacane P, Erickson S. 2000. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res 109:219-227.
5. Golub MS, Germann SL, Lloyd KC. 2004. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav Brain Res 153:159-170.
6. Law AJ, Kleinman JE, Weinberger DR, Weickert CS. 2007. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 16:129-141.
7. Mikhail FM, Lose EJ, Robin NH, Descartes MD, Rutledge KD, Rutledge SL, Korf BR, Carroll AJ. 2011. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. Am J Med Genet A 155A:2386-2396.
8. Neddens J, Buonanno A. 2010. Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 20:724-744.
9. Neddens J, Fish KN, Tricoire L, Vullhorst D, Shamir A, Chung W, Lewis DA, McBain CJ, Buonanno A. 2011. ErbB4 is not detected in pyramidal cells but is confined to interneurons in the frontal cortex of humans, monkeys and rodents: Implications for schizophrenia. Biol Psychiatry 70:636-645.
10. Nicodemus KK, Law AJ, Radulescu E, Luna A, Kolachana B, Vakkalanka R, Rujescu D, Giegling I, Straub RE, McGee K, Gold B, Dean M, Muglia P, Callicott JH, Tan HY, Weinberger DR. 2010. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch Gen Psychiatry 67:991-1001.
11. Stefanis NC, Hatzimanolis A, Smyrnis N, Avramopoulos D, Evdokimidis I, van Os J, Stefanis CN, Straub RE, Weinberger DR. 2011. Schizophrenia Candidate Gene ERB B4: Covert routes of vulnerability to psychosis detected at the population level. Schizophr Bull [Epub ahead of print].
12. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877-892.
13. Tan GH, Liu YY, Hu XL, Yin DM, Mei L, Xiong ZQ. 2011. Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. Nat Neurosci 15:258-266 DOI: 10.1038/nn.3005.
14. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320:539-543.